Current Active Trials
Investigator Matthew Sackett, MD
Real-World Experience – Barostim™. Advancing the Level of Clinical Evidence. A Post-Market Registry with the Barostim™ System.
Investigator Matthew Sackett, MD
Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation (REAL-AF)
Investigator Matthew Sackett, MD
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System use in Conjunction with VISITAG SURPOINT Module for the Treatment of Symptomatic Drug-Refractory Paroxysmal Atrial Fibrillation.
Investigator Matthew Sackett, MD
Real-World Safety and Effectiveness of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Rhythm Control Therapy with the THERMOCOOL SMARTTOUCH® SF Catheter.
Investigator Ronald Morford, MD
A Prospective, Multi-Center, Non-Randomized, Single-Arm Study of the BD™ Low Profile Vascular Covered Stent in Peripheral Artery Disease
Investigator Matthew Sackett, MD
Assessment of the Safety and Efficacy of a Combined Cardiac Contractility Modulation and Implantable Cardioverter Defibrillator Device for Subjects with Heart Failure and Reduced Ejection Fraction.
Investigator Matthew Sackett, MD
A Prospective, Multi-center, Non-randomized, Single Arm Open Label Study of 620 Subjects Receiving the OPTIMIZER® Smart with CCM® Therapy As Standard of Care.
